Charles River Laboratories CRL DSA — SG&A

Other segment segments

Similar metrics at other companies

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

BRKRBsi Calid — Selling General And Administrative Expense

$81.3M+11.5%

RBAOperating Segments — Selling General And Administrative Expense

$101.26M+36.1%

ARWROperating Segment — SG&A

$41.74M+47.0%

VRSKOperating Segments — Selling General And Administrative Expense

$77.81M+10.2%

CLHTotal Segment Revenues — Selling, general and administrative expenses

$129.14M+15.7%

Questions, answered.

What is Charles River Laboratories's DSA — SG&A?

Charles River Laboratories (CRL) reported DSA — SG&A of $47.52M in Q1 2026.

How has Charles River Laboratories's DSA — SG&A changed year-over-year?

Charles River Laboratories's DSA — SG&A decreased by 27.2% year-over-year, from $65.29M to $47.52M.

What is the long-term trend for Charles River Laboratories's DSA — SG&A?

Over 3 years (2022 to 2025), Charles River Laboratories's DSA — SG&A has grown at a 3.9% compound annual growth rate (CAGR), from $213.87M to $239.77M.

What does DSA — SG&A mean?

The overhead and administrative expenses required to run the segment's business operations.

How do you interpret DSA — SG&A?

Rising costs relative to revenue may indicate scaling inefficiencies or increased investment in business development.

How does DSA — SG&A compare across companies?

Standard operating expense category used across all public companies.